Central MA Life Sciences Report 31
A Burgeoning Life Sciences and Biotech Hub
• Highly Skilled and Diverse Workforce
• Central Location and Easy Highway Access
• Local and State Financial Incentives
• Platinum Bio-Ready Community
• Expedited Permitting Procedures
Here We Grow!
MARLBOROUGH, MA
Connect with us today to learn more!
Meredith Harris, Executive Director
508-229-2010
marlboroughedc.com
Why companies are choosing the City of Marlborough:
• Affordable Commercial and Residential Real Estate
• Quality Lifestyle Amenities
• Room For Expansion and Growth
• Home to Leading Life Sciences Players: Boston Scientific,
Cytiva, DuPont, Hologic, Quest Diagnostics and
Sunovion
A selling point
This landscape is helping business
boom at MustangBio, a clinical-stage
biopharmaceutical company, said Debra
Manning, its senior vice president of
human resources. Headquartered in
Worcester, MustangBio was founded in
2015 and has since seen growth year af-
ter year, now with 29,000 square feet of
both research and manufacturing space.
The influx of new biotechnology and life
sciences companies coming to Worcester
and the region's welcoming of Mustang-
Bio is a draw and remains a selling point
for bringing in new employees.
"We know that this area is hoping
to add more biotech, and we love that.
Candidates cite our location as a plus,"
Manning said.
At the end of 2019, MustangBio had
39 employees. As of March 2023, that
number is 110 and still growing, said
Manning. With the growth in employee
count, the footprint of MustangBio's
operations is growing, too. The compa-
ny's Plantation Street address is among
the UMass Chan Medical School-adja-
cent hub, which includes Charles River
Laboratories and AbbVie. The signifi-
cantly lower cost for space in Worcester
as compared to Boston and Cambridge
P
H
O
T
O
/
M
U
S
T
A
N
G
B
I
O
An employee at MustangBio works in the
more than 29,000 square feet of space
the company now occupies in Worcester.
Debra Manning, senior vice president of
human resources at MustangBio
Continued on page 33
Continued from page 29
